Hunter Land

Hunter Land

Company: Lupvindol Biosciences Limited

Job title: Chief Executive Officer

Seminars:

Cannabinoid Combination Therapy Utilizing Corticosteroids & CBD 2:00 pm

Discussing preclinical and clinical data from equine studies demonstrating cartilage growth using CBD – corticosteroid combination therapeutics and insights into patient clinical trials for Crohn’s disease Exploring rational polypharmacy and the strategic drug combination methodologies aimed to reduce individual drug dosage whilst maintaining or enhancing therapeutic effect Analyzing dosing versus formulation and their significance on…Read more

day: Conference Day Two

Panel Discussion: Concurrent Modalities in Cannabinoid Therapeutics: Advances in Synthetic & Botanical Drug Development 4:00 pm

Navigating the differences in the regulatory landscape for botanical and synthetic drugs Discussing how research into both fields has contributed to the overall understanding of cannabinoid pharmacology Validating effectively scaling up in synthetic drug production versus maintaining API consistency in botanical drugsRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.